{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Transglutaminases : Questions médicales les plus fréquentes",
"headline": "Transglutaminases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Transglutaminases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-05",
"dateModified": "2025-04-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Transglutaminases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Aminoacyltransferases",
"url": "https://questionsmedicales.fr/mesh/D019881",
"about": {
"@type": "MedicalCondition",
"name": "Aminoacyltransferases",
"code": {
"@type": "MedicalCode",
"code": "D019881",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.050.200"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protein glutamine gamma glutamyltransferase-2",
"alternateName": "Protein Glutamine gamma Glutamyltransferase 2",
"url": "https://questionsmedicales.fr/mesh/D000091345",
"about": {
"@type": "MedicalCondition",
"name": "Protein glutamine gamma glutamyltransferase-2",
"code": {
"@type": "MedicalCode",
"code": "D000091345",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.050.200.800.650"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Transglutaminases",
"alternateName": "Transglutaminases",
"code": {
"@type": "MedicalCode",
"code": "D011503",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mari T Kaartinen",
"url": "https://questionsmedicales.fr/author/Mari%20T%20Kaartinen",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine (Experimental Medicine), McGill University, Montreal, QC H3A 0J7, Canada."
}
},
{
"@type": "Person",
"name": "Jeffrey W Keillor",
"url": "https://questionsmedicales.fr/author/Jeffrey%20W%20Keillor",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON K1N 6N5, Canada."
}
},
{
"@type": "Person",
"name": "Teea Salmi",
"url": "https://questionsmedicales.fr/author/Teea%20Salmi",
"affiliation": {
"@type": "Organization",
"name": "School of Medicine, University of Tampere, Tampere, Finland."
}
},
{
"@type": "Person",
"name": "Katri Lindfors",
"url": "https://questionsmedicales.fr/author/Katri%20Lindfors",
"affiliation": {
"@type": "Organization",
"name": "Pediatric Research Center, University of Tampere and Tampere University Hospital, Finn Medi 3, 33520, Tampere, Finland. katri.lindfors@uta.fi."
}
},
{
"@type": "Person",
"name": "Vitaliy Kolotylo",
"url": "https://questionsmedicales.fr/author/Vitaliy%20Kolotylo",
"affiliation": {
"@type": "Organization",
"name": "Department of Food Biotechnology and Microbiology, Institute of Food Sciences, Warsaw University of Life Sciences-SGGW, Nowoursynowska 159 C, 02-776 Warsaw, Poland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Deep Neural Networks for Predicting Single-Cell Responses and Probability Landscapes.",
"datePublished": "2023-07-19",
"url": "https://questionsmedicales.fr/article/37467372",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acssynbio.3c00203"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Bayesian approach to estimate the probability of resistance to bedaquiline in the presence of a genomic variant.",
"datePublished": "2023-06-14",
"url": "https://questionsmedicales.fr/article/37315052",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0287019"
}
},
{
"@type": "ScholarlyArticle",
"name": "Joint probability analysis of streamflow and sediment load based on hybrid copula.",
"datePublished": "2023-01-31",
"url": "https://questionsmedicales.fr/article/36719583",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11356-023-25344-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Changes in the probability of hysterectomy in the city of Mainz and Mainz-Bingen region, Germany.",
"datePublished": "2023-01-11",
"url": "https://questionsmedicales.fr/article/36631748",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-022-14916-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Robust PMBM Filter with Unknown Detection Probability Based on Feature Estimation.",
"datePublished": "2022-05-13",
"url": "https://questionsmedicales.fr/article/35632139",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s22103730"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Transferases",
"item": "https://questionsmedicales.fr/mesh/D014166"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acyltransferases",
"item": "https://questionsmedicales.fr/mesh/D000217"
},
{
"@type": "ListItem",
"position": 6,
"name": "Aminoacyltransferases",
"item": "https://questionsmedicales.fr/mesh/D019881"
},
{
"@type": "ListItem",
"position": 7,
"name": "Transglutaminases",
"item": "https://questionsmedicales.fr/mesh/D011503"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Transglutaminases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Transglutaminases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Transglutaminases",
"description": "Comment diagnostiquer une carence en transglutaminases ?\nQuels tests sont utilisés pour évaluer les transglutaminases ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes indiquent un problème de transglutaminases ?\nPeut-on diagnostiquer par imagerie ?",
"url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Probability&page=7#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Transglutaminases",
"description": "Quels sont les symptômes d'une dysfonction des transglutaminases ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes sont-ils immédiats après ingestion ?\nLes symptômes peuvent-ils être confondus avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Probability&page=7#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Transglutaminases",
"description": "Comment prévenir les troubles liés aux transglutaminases ?\nLes tests génétiques aident-ils à la prévention ?\nL'éducation nutritionnelle est-elle importante ?\nLes enfants doivent-ils être testés ?\nPeut-on prévenir les symptômes par des changements de mode de vie ?",
"url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Probability&page=7#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Transglutaminases",
"description": "Quel est le traitement principal pour les troubles liés aux transglutaminases ?\nDes médicaments sont-ils nécessaires ?\nLa supplémentation est-elle recommandée ?\nLes traitements sont-ils efficaces ?\nY a-t-il des traitements alternatifs ?",
"url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Probability&page=7#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Transglutaminases",
"description": "Quelles complications peuvent survenir avec des troubles de transglutaminases ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles fréquentes ?\nY a-t-il un risque accru de cancers ?",
"url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Probability&page=7#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Transglutaminases",
"description": "Quels sont les facteurs de risque pour les troubles de transglutaminases ?\nL'âge joue-t-il un rôle dans le risque ?\nLe sexe influence-t-il le risque ?\nLes antécédents médicaux augmentent-ils le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Probability&page=7#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en transglutaminases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic peut être établi par des tests sanguins mesurant les niveaux d'enzymes spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les transglutaminases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests d'anticorps anti-transglutaminase tissulaire sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie intestinale peut être nécessaire pour confirmer une maladie cœliaque associée."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de transglutaminases ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la diarrhée, la fatigue et les douleurs abdominales peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer par imagerie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie n'est pas utilisée pour diagnostiquer les problèmes de transglutaminases."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une dysfonction des transglutaminases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles digestifs, des éruptions cutanées et une fatigue chronique."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier, les enfants présentant souvent des symptômes digestifs plus marqués."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes neurologiques comme des maux de tête peuvent survenir en cas de carence."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils immédiats après ingestion ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître plusieurs heures ou jours après l'ingestion d'aliments problématiques."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être confondus avec d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être similaires à ceux d'autres troubles digestifs comme le syndrome de l'intestin irritable."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux transglutaminases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par un régime alimentaire sans gluten pour ceux à risque de maladie cœliaque."
}
},
{
"@type": "Question",
"name": "Les tests génétiques aident-ils à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les personnes à risque de développer des troubles."
}
},
{
"@type": "Question",
"name": "L'éducation nutritionnelle est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les aliments contenant du gluten est cruciale pour la prévention."
}
},
{
"@type": "Question",
"name": "Les enfants doivent-ils être testés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants ayant des antécédents familiaux de maladie cœliaque devraient être testés."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les symptômes par des changements de mode de vie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements de mode de vie, comme une alimentation équilibrée, peuvent aider à prévenir les symptômes."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour les troubles liés aux transglutaminases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est un régime sans gluten pour les personnes atteintes de maladie cœliaque."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour traiter les symptômes, mais pas pour la cause sous-jacente."
}
},
{
"@type": "Question",
"name": "La supplémentation est-elle recommandée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La supplémentation en vitamines et minéraux peut être nécessaire en cas de carences nutritionnelles."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un régime strict sans gluten est généralement très efficace pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs comme l'acupuncture sont explorés, mais leur efficacité n'est pas prouvée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des troubles de transglutaminases ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des carences nutritionnelles, des troubles auto-immuns et des cancers intestinaux."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications, comme les carences, peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent gravement affecter la qualité de vie en provoquant des douleurs et des limitations."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont fréquentes chez les personnes non traitées pour la maladie cœliaque."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de cancers ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes atteintes de maladie cœliaque non traitée ont un risque accru de cancers intestinaux."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles de transglutaminases ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des infections intestinales."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque est plus élevé chez les jeunes enfants et les adultes jeunes."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont plus souvent diagnostiquées avec des troubles liés aux transglutaminases."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies auto-immunes augmentent le risque de troubles de transglutaminases."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs comme l'alimentation et les infections peuvent influencer le risque."
}
}
]
}
]
}
Engineering biology relies on the accurate prediction of cell responses. However, making these predictions is challenging for a variety of reasons, including the stochasticity of biochemical reactions...
Bedaquiline is a core drug for treatment of rifampicin-resistant tuberculosis. Few genomic variants have been statistically associated with bedaquiline resistance. Alternative approaches for determini...
Using published phenotype data for variants in Rv0678, atpE, pepQ and Rv1979c genes in 756 Mycobacterium tuberculosis isolates and survey data of the opinion of 33 experts, we applied Bayesian methods...
Experts agreed on the role of Rv0678, and atpE, were uncertain about the role of pepQ and Rv1979c variants and overestimated the probability of bedaquiline resistance for most variant types, resulting...
Bayesian probability estimates of bedaquiline resistance given the presence of a specific mutation could be useful for clinical decision-making as it presents interpretable probabilities compared to s...
Statistical analysis of streamflow and sediment is very important for integrated watershed management and the design of water infrastructure, especially in silt-rich rivers. Here, we propose a bivaria...
To assess the hysterectomy probability by calendar period and age, the overall and the age-specific prevalence of hysterectomy in women aged 30-65 years....
Baseline data (2005-2007) from the population-based MARZY study conducted in Mainz and Mainz-Bingen, Germany, were analysed. 6429 women aged 30-65 years were asked whether they had undergone a hystere...
Data on hysterectomy were available for 4719 women. Of these, 961 (20.4%) had undergone a hysterectomy between 1960 and 2006. The hysterectomy prevalence was highest among the 60-64 year-olds (40.7%)....
A shift to older age at hysterectomy with an advancing calendar period likely reflects changes in clinical practice in Germany....
Landesärztekammer Rheinland-Pfalz: 837.438.03 (4100)....
This paper provides a solution for multi-target tracking with unknown detection probability. For the standard Poisson Multi-Bernoulli Mixture (PMBM) filter, the detection probability is generally cons...
The probability density analysis was applied to automatically characterize the center of pressure (COP) data for evaluation of the stroke patients' balance ability....
The real-time COP coordinates of 38 stroke patients with eyes open and closed during quiet standing were obtained, respectively, from a precision force platform. The COP data were analyzed and charact...
The PA from probability density analysis is strongly correlated with SL and SR. Both the traditional parameters and probability density parameters in the EC state are significantly different from thos...
The probability density analysis of COP data can be used to characterize the posturography for evaluation of the balance ability of stroke patients....
Nearly all asthma predictive tools estimate the future risk of asthma development. However, there is no tool to predict the probability of successful ICS cessation at an early age. Therefore, we aimed...
Predictors of less successful ICS cessation were the following: perinatal oxygen use, allergic rhinitis, blood eosinophil count > 500 cell/mm...
• Early allergic sensitization is associated with reduced chances of inhaled corticosteroid cessation at school age. • Prolonged ICS is associated with the emergence of adverse effect and discontinuin...
• Requirement of oxygen support within 7 days after birth in term neonate is a postnatal factor associated with less successful ICS cessation. • We propose a simple predictive tool with easily availab...
Among other diseases, Covid 19 creates a critical situation around the world. Five layers have been recorded so far, resulting in the loss of millions of lives in different countries. The virus was th...
Information processing in the brain is controlled by quantal release of neurotransmitters, a tightly regulated process. From ultrastructural analysis, it is known that presynaptic boutons along single...
Cognitive models of social anxiety propose that overestimation of the probability and cost of negative evaluation plays a central role in maintaining the disorder. However, there are currently no self...